Chemotherapeutic Interaction of Vernonia Amygdalina (Delile) Leaf Extract with Artesunate and Amodiaquine in Murine Malaria Model

dc.contributor.authorOsirim, Esthinsheen
dc.date.accessioned2022-05-09T13:10:49Z
dc.date.available2022-05-09T13:10:49Z
dc.date.issued2020-03-27
dc.description.abstractAim of the Study: Conventional antimalarial drugs are used concurrently with herbal remedies in malarial endemic developing countries. Vernonia amygdalina is one of such popular herbs used in the treatment of malaria. This study aimed at investigating the antimalarial chemotherapeutic interaction of Vernonia amygdalina (VA) when combined with Amodiaquine (AQ) and/or Artesunate (AS) in a murine Plasmodium berghei malaria model. Methodology: Various doses of aqueous VA leaf extract (100-500 mg/kg/day), AQ (2-10 mg/kg/day) and AS (0.8-4 mg/kg/day) were administered orally to P berghei.-infected Swiss albino mice to determine their sub-therapeutic doses. These doses were subsequently used to investigate the chemotherapeutic interactions of VA with AQ and/or AS in both early and established malaria infection test models. The survival of animals with established infections that received different drug/herb treatments were determined using their mean survival time (days) and Kaplan-Meier survival curves (percentage). Using GraphPad Instat (version 3.10) and PrismR (version 5.01) the data obtained were subjected to One-way ANOVA, followed by Student-Newman-Keuls test. P < .05 was considered statistically significant. Results: The sub-therapeutic doses of VA, AQ and AS were found to be 100 mg/kg, 2 mg/kg and 2.4 mg/kg, respectively. The chemosuppressive effect of AQ or AS was significantly increased (p< 0.05) when administered in combination with the VA extract. Similarly, combination of VA extract with AQ or AS resulted in significant (P < .05) parasite clearance when compared to the effects of the herb or the conventional drugs administered separately. The mean survival period of animals with established infection was also significantly enhanced by the VA alone or with AQ (or AS) compared to placebo.en_US
dc.identifier.issn2231-2919
dc.identifier.urihttp://dspace.run.edu.ng:8080/jspui/handle/123456789/2935
dc.language.isoenen_US
dc.publisherJournal of Pharmaceutical Research Internationalen_US
dc.relation.ispartofseries33(3):;15-24, JPRI.55297
dc.subjectChemotherapeutic interactionen_US
dc.subjectMurine malaria modelen_US
dc.subjectVernonia amygdalinaen_US
dc.subjectArtesunateen_US
dc.subjectAmodiaquineen_US
dc.titleChemotherapeutic Interaction of Vernonia Amygdalina (Delile) Leaf Extract with Artesunate and Amodiaquine in Murine Malaria Modelen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
VAmydalinaAD-ASInteration.pdf
Size:
298.09 KB
Format:
Adobe Portable Document Format
Description:
journal article
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: